Lilly Alzheimer’s Drug Flunks One Test, Shows Results In Other
The results are out on the two late-stage clinical trials that Eli Lilly was running on a potential Alzheimer’s drug, and what you think about them depends on whether you tend to see the glass half empty or half full. Lily’s tests on the drug solanezumab didn’t attain their goal,..
Read more
